RxDoctor Payments DataLook up a doctor →

Drew Venables

Physician Assistant · Lewes, DENPI 1053795997

Payments from drug & device makers

$12,469in general payments, 2019–2025

Across 609 payments — averaging $20.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Johnson & Johnson$2K
  • Novartis$1K
  • Lilly USA, LLC$1K
  • Sanofi$1K
  • E.r. Squibb & Sons, L.L.C.$804
  • plus $5K from 24 others

What the payments were for

  • Food & beverage$12,11597%
  • Education$3543%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,469 in reported general payments places this provider in the 95th percentile of 527 physician assistant providers in Delaware.

See all physician assistant providers in Delaware

Medicare billing

Part B allowed, 2024
$231,669
Medicare patients
1,363
Services billed
4,997

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Skyrizi PenRisankizumab-Rzaa26$565,128
Dupixent PenDupilumab107$452,521
Cosentyx Sensoready (2 Pens)Secukinumab32$285,826
Dupixent SyringeDupilumab53$198,863
Clobetasol Propionate182$8,506
Fluorouracil85$6,494
Tacrolimus36$5,034
Pimecrolimus26$4,545
Ketoconazole206$3,976
Betamethasone Dipropionate64$3,521
Triamcinolone Acetonide236$2,967
Azelaic Acid21$2,627
Cyproheptadine Hcl97$2,258
Tretinoin34$1,988
Metronidazole37$1,886

Paid to pharmacies, not to this prescriber.

Other physician assistant in Lewes

See the full list for Delaware

Where these figures come from

Is this you, or does something look wrong? →